Philip Tarr

Prof. Dr med. Philip Tarr graduated from University of Zurich Medical School. He completed his residency in Internal Medicine at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston, fellowship in Infectious Diseases at the National Institutes of Health in Bethesda MD, and obtained research training into the genetics of metabolic complications in HIV with Amalio Telenti at University Hospital Lausanne. Tarr is chairman of the Swiss HIV Cohort Study’s (SHCS) core project Metabolism and Aging, chief of infectious diseases and, since 2016, has been co-chairman of the University Medical Department of Kantonsspital Baselland, University of Basel. His research has been supported by the Swiss National Science Foundation since 2009. Recent projects include a comparison of subclinical atherosclerosis in HIV+ and HIV- persons using coronary CT angiography, published in the European Heart Journal, identification of abacavir as contributing to atherosclerotic plaque in HIV, characterization of genetic background associated with chronic kidney disease in the SHCS, and documentation of an association of telomere length with acute coronary events in the SHCS, all published in Clinical Infectious Diseases.